Strategic management of pharmaceutical supply chains during pandemic disruptions: A qualitative study in South Africa
Blessing Takawira · David Pooe
International Journal of Business Ecosystem & Strategy · 2026 · Vol. 7 / Issue 6 · 699-721
Publication metrics
External links open provider records or DOI searches. Provider counts are not combined. Mendeley readership measures saves, not citations.
Dimensions
Live provider badge. If unavailable, use the Dimensions link above.
Observed 21 Oct 2026, 00:14 UTC
Observed 21 Oct 2026 00:14 UTC
OpenAlex and Mendeley observations refresh on article visits, at most once per 24 hours. Unavailable data is not zero. Google Scholar opens a DOI search.
Citations received by this article, grouped by the year of the citing work. Crossref and OpenAlex lifetime totals remain separate in Publication metrics.
2017–2026 Annual history last updated:
Citations received
OpenAlex · year of the citing work
Hover over a year or focus the chart and use arrow keys to inspect values.
2017–2026 annual-history window. 2026 is year to date. Unknown years have gaps.
View data & coverage
2026 is incomplete. Within a successfully fetched ten-year window, omitted years mean zero. Years beyond a saved observation’s window remain unknown (—). Older citations are excluded, so this chart’s sum may differ from the OpenAlex lifetime total. The date above belongs to this annual history; an unsuccessful refresh keeps the previous observation.
Abstract
This research investigates the strategic management of pharmaceutical supply chains in South Africa, with a focus on responses to disruptions resulting from the COVID-19 pandemic. The study explores how supply chain professionals navigated unprecedented challenges and implemented resilience strategies during this crisis. A qualitative, exploratory phenomenological approach was employed using semi-structured interviews with 25 pharmaceutical supply chain professionals selected through purposive sampling. Participants represented diverse segments of the pharmaceutical supply chain, including manufacturers, distributors, wholesalers, and retailers. Data were analysed using thematic analysis with Atlas.ti software to identify patterns and relationships within participant experiences. Four major themes emerged from the analysis: (1) disruptions in supply chains due to COVID-19, characterised by panic buying, logistical challenges, and inconsistent supply; (2) impact on strategic decision-making and operational performance, including implementation of skeleton staffing and increased operational costs; (3) resilience and responsiveness strategies, focusing on supplier relationships, enhanced demand forecasting, and increased local production; and (4) lessons learned and future preparedness, emphasising disaster management frameworks and technological advancements. The study highlights the importance of developing balanced strategic approaches that address immediate disruptions and long-term resilience in pharmaceutical supply chains. Key findings reveal that effective strategic management during crises requires simultaneous attention to operational adjustments (skeleton staffing, remote work) and strategic initiatives (local production, technological investment). These insights contribute to understanding how pharmaceutical supply chains in developing economies can enhance resilience against future disruptions through strategic management practices that balance reactive and proactive approaches.
Authors & affiliations
Blessing Takawira
University of Johannesburg
David Pooe
University of Johannesburg
Deposited references
Supplied references, not a list of publications citing this article.
No reference list supplied.